S&P 500 Futures
(0.32%) 5 107.75 points
Dow Jones Futures
(0.69%) 38 646 points
Nasdaq Futures
(0.63%) 17 760 points
Oil
(-0.04%) $78.92
Gas
(0.20%) $2.04
Gold
(0.02%) $2 310.10
Silver
(-0.22%) $26.77
Platinum
(1.37%) $975.80
USD/EUR
(-0.15%) $0.931
USD/NOK
(-0.49%) $10.94
USD/GBP
(-0.19%) $0.796
USD/RUB
(0.55%) $91.63

リアルタイムの更新: CryoLife Inc [CRY]

取引所: NYSE セクター: Healthcare 産業: Medical Devices
最終更新日時24 1月 2022 @ 14:00

1.42% $ 17.88

Live Chart Being Loaded With Signals

Commentary (24 1月 2022 @ 14:00):

Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. It offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, pulmonary, and general surgical applications; On-X prosthetic aortic and mitral heart valve, and On-X ascending aortic prosthesis; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita OPEN PLUS and E-vita OPEN NEO, a hybrid stent graft system...

Stats
本日の出来高 257 460
平均出来高 200 073
時価総額 725.15M
EPS $-0.513 ( 2022-02-09 )
Last Dividend $0.0300 ( 2015-12-09 )
Next Dividend $0 ( N/A )
P/E 425.71
ATR14 $0.701 (3.92%)
Insider Trading
Date Person Action Amount type
2021-06-01 Salveson Jon W Buy 4 423 Common Stock
2021-06-01 Morgan Harvey Buy 4 423 Common Stock
2021-06-01 Burbank Jeffrey H Buy 4 423 Common Stock
2021-04-30 Horton Amy Buy 2 700 Common Stock
2021-04-30 Horton Amy Sell 2 700 Common Stock
INSIDER POWER
0.00
Last 100 transactions
Buy: 1 202 389 | Sell: 548 438

ボリューム 相関

長: -0.18 (neutral)
短: -0.10 (neutral)
Signal:(36.808) Neutral

CryoLife Inc 相関

10 最も正の相関
YSAC0.88
NMZ0.834
10 最も負の相関

知っていましたか?

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

CryoLife Inc 相関 - 通貨/商品

The country flag -0.74
( moderate negative )
The country flag -0.73
( moderate negative )
The country flag 0.24
( neutral )
The country flag -0.53
( weak negative )
The country flag 0.38
( neutral )
The country flag 0.46
( neutral )

CryoLife Inc 財務諸表

Annual 2023
収益: $354.00M
総利益: $213.98M (60.45 %)
EPS: $-0.750
FY 2023
収益: $354.00M
総利益: $213.98M (60.45 %)
EPS: $-0.750
FY 2022
収益: $313.79M
総利益: $202.52M (64.54 %)
EPS: $-0.480
FY 2021
収益: $298.84M
総利益: $197.51M (66.09 %)
EPS: $-0.392

Financial Reports:

No articles found.

CryoLife Inc Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

CryoLife Inc Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 3.78 - low (25.86%) | Divividend Growth Potential Score: 2.22 - No dividend growth expected in the near future
Information
First Dividend $0.0250 2012-09-12
Last Dividend $0.0300 2015-12-09
Next Dividend $0 N/A
Payout Date 2015-12-18
Next Payout Date N/A
# dividends 14 --
Total Paid Out $0.395 --
Avg. Dividend % Per Year 0.00% --
Score 2.54 --
Div. Sustainability Score 3.78
Div.Growth Potential Score 2.22
Div. Directional Score 3.00 --
Next Divdend (Est)
(2024-06-20)
$0 Estimate 0.00 %
Dividend Stability
0.06 Very Bad
Dividend Score
2.54
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield
2012 $0.0500 1.04%
2013 $0.108 1.61%
2014 $0.118 1.06%
2015 $0.120 1.07%
2016 $0 0.00%
2017 $0 0.00%
2018 $0 0.00%
2019 $0 0.00%
2020 $0 0.00%
2021 $0 0.00%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NYSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
LOMA Dividend Knight 2023-06-30 Quarterly 2 5.23% 8.53
PVL Dividend King 2023-11-15 Monthly 14 9.37% 8.50
NCV Dividend Royal 2024-02-09 Monthly 22 7.68% 8.50
KIO Dividend Royal 2023-12-14 Monthly 12 7.05% 8.50
SBR Dividend Royal 2023-11-14 Monthly 38 7.74% 8.50
SCM Dividend King 2023-12-15 Monthly 13 7.08% 8.50
MTR Dividend Diamond 2023-10-30 Monthly 39 10.10% 8.50
SJT Dividend Royal 2023-11-29 Monthly 39 12.52% 8.50
PDI Dividend Royal 2023-11-10 Monthly 13 7.86% 8.50
GOF Dividend Royal 2023-11-14 Monthly 18 8.03% 8.50

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.08671.500-1.734-2.60[0 - 0.5]
returnOnAssetsTTM-0.03871.200-1.291-1.549[0 - 0.3]
returnOnEquityTTM-0.1101.500-2.33-3.50[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM3.990.80010.008.00[1 - 3]
quickRatioTTM2.300.8001.1770.942[0.8 - 2.5]
cashRatioTTM1.0191.5005.458.18[0.2 - 2]
debtRatioTTM0.394-1.5003.44-5.16[0 - 0.6]
interestCoverageTTM0.2681.000-1.012-1.012[3 - 30]
operatingCashFlowPerShareTTM0.4542.009.8510.00[0 - 30]
freeCashFlowPerShareTTM0.2732.009.8610.00[0 - 20]
debtEquityRatioTTM1.107-1.5005.57-8.36[0 - 2.5]
grossProfitMarginTTM0.6471.0002.542.54[0.2 - 0.8]
operatingProfitMarginTTM0.01921.000-1.617-1.617[0.1 - 0.6]
cashFlowToDebtRatioTTM0.05951.000-0.780-0.780[0.2 - 2]
assetTurnoverTTM0.4470.800-0.355-0.284[0.5 - 2]
Total Score3.78

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-27.391.000-2.870[1 - 100]
returnOnEquityTTM-0.1102.50-1.500-3.50[0.1 - 1.5]
freeCashFlowPerShareTTM0.2732.009.9110.00[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM0.4542.009.8510.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.5931.5009.380[0.5 - 2]
operatingCashFlowSalesRatioTTM0.05251.000-1.1880[0.1 - 0.5]
Total Score2.22

CryoLife Inc

Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. It offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, pulmonary, and general surgical applications; On-X prosthetic aortic and mitral heart valve, and On-X ascending aortic prosthesis; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita OPEN PLUS and E-vita OPEN NEO, a hybrid stent graft system. The company also provides E-xtra DESIGN ENGINEERING products for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system. In addition, it offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; and cardiac laser therapy products, such as SolarGen 2100s Console and SoloGrip III disposable handpieces. Further, the company sells CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as offers pyrolytic carbon coating services to other medical device manufacturers. The company serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion Inc. in January 2022. Artivion Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。